Letter to the Editor: Immortal time bias or sorafenib effect in elderly patients with HCC?

dc.contributor.authorSanoff, Hanna K.
dc.contributor.authorChang, YunKyung
dc.contributor.authorLund, Jennifer L.
dc.contributor.authorO'Neil, Bert H.
dc.contributor.authorDusetzina, Stacie B.
dc.contributor.departmentDepartment of Medicine, IU School of Medicineen_US
dc.date.accessioned2017-08-02T13:56:43Z
dc.date.available2017-08-02T13:56:43Z
dc.date.issued2017-08
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationSanoff, H. K., Chang, Y., Lund, J. L., O'Neil, B. H. and Dusetzina, S. B. (2017), Letter to the Editor: Immortal Time Bias or Sorafenib Effect in Elderly Patients with HCC?. Hepatology, 66 (2), 678-679. http://dx.doi.org/10.1002/hep.29250en_US
dc.identifier.urihttps://hdl.handle.net/1805/13696
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1002/hep.29250en_US
dc.relation.journalHepatologyen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectsorafeniben_US
dc.subjecthepatocellular carcinomaen_US
dc.subjectimmortal time biasen_US
dc.titleLetter to the Editor: Immortal time bias or sorafenib effect in elderly patients with HCC?en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Sanoff_2017_letter.pdf
Size:
178.58 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: